J. Cabiedes

发表

Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.

Y. Richaud-Patin, L. Llorente, E. Carrillo-Maravilla, 2003, Immunology letters.

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.

D. Alarcón-Segovia, M. Amigo, A. Cabral, 1996, The American journal of medicine.

Prevalence and Factors Associated with Headache in Patients with Systemic Lupus Erythematosus

M. Guibert-Toledano, G. García-Ramos, M. Cardiel, 2004, Cephalalgia : an international journal of headache.

Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

J. Sánchez-Guerrero, D. Alarcón-Segovia, J. Cabiedes, 1989, Medicine.

Utility of Serum S100B Protein for Identification of Central Nervous System Involvement in Systemic Lupus Erythematosus

J. Sánchez-Guerrero, L. Llorente, H. Fragoso-Loyo, 2010, The Journal of Rheumatology.

Involvement in Systemic Lupus Erythematosus Utility of Serum S 100 B Protein for Identification of Central Nervous System

J. Sánchez-Guerrero, L. Llorente, H. Fragoso-Loyo, 2010 .

Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

J. Sánchez-Guerrero, B. Diamond, Y. Richaud-Patin, 2009, Rheumatology.

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy

J. Cabiedes, A. Cabral, GN Damián-Abrego, 2008, Lupus.

Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis

J. Sánchez-Guerrero, B. Diamond, L. Llorente, 2008, PloS one.

Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-β2-glycoprotein-I antibodies

E. Reyes, A. Cabral, J. Cabiedes, 2005 .

Heterogeneity of antibodies to β2-glycoprotein 1 from patients with systemic lupus erythematosus

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 2004 .

Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome

J. Alcocer-Varela, J. Rojas-Serrano, J. Simón, 2004, Lupus.

Antiprothrombin Antibodies in Patients With Systemic Lupus Erythematosus or With Primary Antiphospholipid Syndrome

D. Alarcón-Segovia, F. Salcido-Ochoa, A. Cabral, 2002, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Clinical and immunogenetic characterization of Mexican patients with ‘Rhupus’

J. Granados, J. Simón, J. Cabiedes, 2002, Lupus.

Potential Additional Effect of Omentectomy on Metabolic Syndrome, Acute-Phase Reactants, and Inflammatory Mediators in Grade III Obese Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass

C. Aguilar-Salinas, D. Velázquez-Fernández, M. Herrera, 2010, Diabetes Care.

Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.

D. Alarcón-Segovia, A. Villa, C. Drenkard, 1993, The Journal of rheumatology.

Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Journal of immunological methods.

Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1995, The Journal of rheumatology.

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.

D. Alarcón-Segovia, A. Villa, C. Drenkard, 1992, Seminars in arthritis and rheumatism.

Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1990, Journal of autoimmunity.

Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.

C. Aguilar-Salinas, I. Cruz-Bautista, P. Almeda-Valdés, 2015, Clinica chimica acta; international journal of clinical chemistry.

Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies.

D. Alarcón-Segovia, A. Villa, A. Cabral, 2003, Arthritis and rheumatism.

Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1995, The Journal of rheumatology.

Distinguishing Between Anti-Neutrophil Cytoplasmic Antibody Patterns in Inflammatory Bowel Disease: Is the “Atypical Pattern” Adding More Information?

A. Montano‐Loza, J. Yamamoto-Furusho, A. Torre, 2009, The American Journal of Gastroenterology.

Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study

M. Diaz-Zamudio, L. Llorente, T. Rodríguez-Reyna, 2012, Rheumatology International.

Characterization of monoclonal anti-beta2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome.

V. Pascual, B. Becerril, A. Cabral, 2006, Journal of autoimmunity.

Anti-β2-glycoprotein-I antibodies in scFv format

A. Cabral, J. Cabiedes, 2005 .

Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients

D. Alarcón-Segovia, A. Cabral, C. Drenkard, 1999 .

Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1992, The American journal of medicine.

Anti-Cardiolipin, Anti-Cardiolipin Plus Bovine, or Human β2Glycoprotein-I and Anti-Human β2Glycoprotein-I Antibodies in a Healthy Infant Population

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 2002 .

Polimorfismo de la β2-glucoproteína I. Relevancia en el síndrome de antifosfolípidos

A. Cabral, J. Cabiedes, G. Prieto, 2002 .

Hidden anti‐phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1998, European journal of immunology.

Cellular immune response to β2-glycoprotein-I valine/leucine247 phenotypes in Mexican patients with primary antiphospholipid syndrome.

C. Nuñez-Alvarez, A. Cabral, A. Ortega, 2017, Human immunology.

Characterization of anti-phosphatidylcholine polyreactive natural autoantibodies from normal human subjects.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 2002, Journal of autoimmunity.

Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.

J. Alcocer-Varela, A. Villa, F. J. van der Woude, 2003, Rheumatology.

Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome.

D. Alarcón-Segovia, A. Villa, R. Ortíz-López, 1991, The Journal of rheumatology.

Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy.

D. Alarcón-Segovia, A. Villa, A. Cabral, 2002, Archives of medical research.

Detection of anticardiolipin antibodies in heat-inactivated normal human sera is not influenced by beta 2-glycoprotein-I.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1993, Thrombosis research.

Antinuclear antibodies: A marker associated with steroid dependence in patients with ulcerative colitis

J. Yamamoto-Furusho, C. Garcı́a-Martı́nez, J. Cabiedes, 2008, Inflammatory bowel diseases.

[Serological markers in inflammatory bowel disease: differences among populations and limitations of their application].

J. Yamamoto-Furusho, J. Cabiedes, J. Hernández-Calleros, 2009, Gastroenterology & hepatology.

Pathogenic mechanisms of the anti-phospholipid antibodies

C. Nuñez-Alvarez, J. Cabiedes, 2011 .

Some patients with primary antiphospholipid syndrome have increased circulating CD5+ B cells that correlate with levels of IgM antiphospholipid antibodies.

J. Sánchez-Guerrero, D. Alarcón-Segovia, J. Alcocer-Varela, 1991, Clinical and experimental rheumatology.

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.

J. Sánchez-Guerrero, J. Simón, E. Ortíz, 2003, Rheumatology.

Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Autoimmunity.

Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.

J. Sánchez-Guerrero, D. Alarcón-Segovia, J. Cabiedes, 1992, Journal of autoimmunity.

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability

A. Villa, J. Cabiedes, I. Contreras-Yáñez, 2009, Arthritis research & therapy.

Urinary sediment analysis

C. Nuñez-Alvarez, J. Cabiedes, Martha E. Baños-Laredo, 2010 .

Urinary sediment analysis

C. Nuñez-Alvarez, J. Cabiedes, Martha E. Baños-Laredo, 2010 .

Continuing medical education Citrullinated proteins in Rheumatoid Arthritis ☆

C. Nuñez-Alvarez, J. Cabiedes, D. Ramírez, 2017 .

Citrullinated proteins in rheumatoid arthritis

C. Nuñez-Alvarez, J. Cabiedes, Elizabeth Olivares Martínez, 2011 .

Continuing medical education Pathogenic mechanisms of the antiphospholipid antibodies ☆

C. Nuñez-Alvarez, J. Cabiedes, 2017 .

[Pathogenic mechanisms of the anti-phospholipid antibodies].

C. Nuñez-Alvarez, J. Cabiedes, 2011, Reumatologia clinica.

The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1997, The Journal of rheumatology.

Persistence on therapy is a major determinant of patient-, physician- and laboratory- reported outcomes in recent-onset rheumatoid arthritis patients.

A. Villa, J. Cabiedes, I. Contreras-Yáñez, 2010, Clinical and experimental rheumatology.

Identification of four subpopulations of IgG anticardiolipin antibodies in patients with primary antiphospholipid syndrome on the basis of their requirement for beta 2-glycoprotein-I and their unmasking by heat.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Clinical and experimental rheumatology.

High prevalence of protein-dependent and protein-independent antiphospholipid and other autoantibodies in healthy elders.

Y. Richaud-Patin, L. Llorente, J. Cabiedes, 2000, Thrombosis research.

Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.

D. Alarcón-Segovia, A. Villa, A. Cabral, 1999, The American journal of medicine.

[Immunological Techniques that Support the Diagnosis of the Autoimmune Diseases].

J. Cabiedes, Diego F Hernández Ramírez, 2010, Reumatologia clinica.

Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs

S. Ponce de León, J. Cabiedes, I. Contreras-Yáñez, 2010, The American journal of the medical sciences.

P012 - Atypical perinuclear anti-neutrophil cytoplasmic antibodies (x-ANCA) are associated with disease extent and arthralgia in patients with ulcerative colitis

J. Yamamoto-Furusho, J. Cabiedes, J. Barahona-Garrido, 2009 .

Atypical perinuclear anti-neutrophil cytoplasmic antibodies (X-ANCA) are associated with disease extent and arthralgia in patients with Ulcerative Colitis: P-0102.

J. Yamamoto-Furusho, J. Cabiedes, J. Barahona-Garrido, 2008 .

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.

J. Sánchez-Guerrero, J. Alcocer-Varela, J. Simón, 2004, Rheumatology.

Patients and Methods

I. Dudkiewicz, J. Alcocer-Varela, A. Blankstein, 2022 .

Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia

Y. Richaud-Patin, I. García-Valladares, D. Elías-López, 2006, Lupus.

[Synovial fluid analysis].

C. Núñez, J. Cabiedes, A. Martínez-Castillo, 2010, Reumatologia clinica.